- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Teva Pharmaceutical Industries Ltd
+ Add to WatchlistTEVA:US
39.9001 USD 0.2899 0.72%As of 12:27:03 ET on 05/21/2013.
Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)
| Open: | 40.0200 | Day's Range: | 39.8301 - 40.1200 | Volume: | 1,514,714 |
|---|---|---|---|---|---|
| Previous Close: | 40.1900 | 52wk Range: | 36.6300 - 42.8300 | 1-Yr Rtn: | +5.34% |
Key Statistics for TEVA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 7.9689 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 5.0220 |
| Est. PEG Ratio | 1.0842 |
| Market Cap (M USD) | 34,057.02 |
| Shares Outstanding (M) | 851.00 |
| 30 Day Average Volume | 3,881,374 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 3.20% |
| Cash Dividend (USD) | 0.2720 |
| Last Dividend | 05/16/2013 |
| 5 Year Dividend Growth | 20.20% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for TEVA
Company Profile & Key Executives for TEVA
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
| Phillip FrostChairman | Jeremy M LevinPresident/CEO |
| Allan ObermanPresident & CEO:Americas | Robert Koremans "Rob"President & CEO:Europe |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
TEVA News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page